(Q78139435)

English

Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases

scientific article published on 01 August 1999

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10451066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10451066%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 December 2019

title

Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10451066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10451066%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference

Asten P

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10451066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10451066%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 December 2019

Barrett J

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10451066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10451066%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 December 2019

Symmons D

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10451066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10451066%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 December 2019

language of work or name

English

0 references

publication date

1 August 1999

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10451066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10451066%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 December 2019

published in

The Journal of Rheumatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10451066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10451066%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 December 2019

volume

26

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10451066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10451066%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 December 2019

issue

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10451066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10451066%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 December 2019

page(s)

1705-1714

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10451066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10451066%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 December 2019

Identifiers

PubMed publication ID

10451066

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10451066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10451066%20AND%20SRC:MED&resulttype=core&format=json

(Q78139435)

Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)